Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complication in Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02547922
What this trial is testing

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
AstraZeneca 147
Not applicableUnknownNCT03171103
What this trial is testing

Systemic Lupus and Adverse Pregnancy Outcome

Who this might be right for
Systemic Lupus ErythematosusPregnancy Complications
Beni-Suef University 100
Post-approval studies (Phase 4)Ended earlyNCT01316133
What this trial is testing

Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Astellas Pharma Korea, Inc. 37
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Study completedNCT02550652
What this trial is testing

Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 126
Not applicableLooking for participantsNCT07575347
What this trial is testing

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

Who this might be right for
Periodontal DiseasePeriodontitisCKD+6 more
Stefan Lujinschi 100
Large-scale testing (Phase 3)Looking for participantsNCT06711887
What this trial is testing

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 348
Testing effectiveness (Phase 2)UnknownNCT00569101
What this trial is testing

A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Seoul National University Hospital 9
Not applicableStudy completedNCT00298506
What this trial is testing

Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

Who this might be right for
Lupus Nephritis
Nanjing University School of Medicine 120
Not applicableStudy completedNCT04239521
What this trial is testing

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Who this might be right for
Alopecia AreataDepressive EpisodeRecurrent Depressive Disorder+33 more
Momentum Data 51,955
Large-scale testing (Phase 3)Ended earlyNCT02514967
What this trial is testing

CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals 3
Testing effectiveness (Phase 2)UnknownNCT03580291
What this trial is testing

Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Lingyun Sun 230
Testing effectiveness (Phase 2)Ended earlyNCT04564339
What this trial is testing

Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A Nephropathy
Alexion Pharmaceuticals, Inc. 123
Testing effectiveness (Phase 2)Study completedNCT02141672
What this trial is testing

AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 265
Large-scale testing (Phase 3)Study completedNCT01639339
What this trial is testing

Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Human Genome Sciences Inc., a GSK Company 448
Early research (Phase 1)Looking for participantsNCT07491900
What this trial is testing

HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Extra-renal Lupus (ERL)
Hinge Bio 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117
What this trial is testing

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Novartis Pharmaceuticals 21
Not applicableStudy completedNCT00935389
What this trial is testing

Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria

Who this might be right for
Lupus NephritisProteinuriaCTX
Nanjing University School of Medicine 44
Not applicableNot Yet RecruitingNCT07505576
What this trial is testing

Anti-alpha-actinin Antibodies and Lupus Nephritis Activity

Who this might be right for
Lupus Nephritis
Assiut University 96
Testing effectiveness (Phase 2)Looking for participantsNCT05268289
What this trial is testing

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 240
Next Page